Whole genome sequencing (WGS) is rapidly approaching widespread clinical application. Technology advancements over the past decade, since the first human genome was decoded, have made it feasible to use WGS for clinical care. Future advancements will likely drive down the price to the point wherein WGS is routinely available for care. However, were this to happen today, most of the genetic information available to guide clinical care would go unused due to the complexity of genetics, limited physician proficiency in genetics, and lack of genetics professionals in the clinical workforce. Furthermore, these limitations are unlikely to change in the future. As such, the use of clinical decision support (CDS) to guide genome-guided clinical decision-making is imperative. In this manuscript, we describe the barriers to widespread clinical application of WGS information, describe how CDS can be an important tool for overcoming these barriers, and provide clinical examples of how genome-enabled CDS can be used in the clinical setting. © 2013 by the authors; licensee MDPI, Basel, Switzerland.
CITATION STYLE
Welch, B. M., & Kawamoto, K. (2013). The need for clinical decision support integrated with the electronic health record for the clinical application of whole genome sequencing information. Journal of Personalized Medicine, 3(4), 306–325. https://doi.org/10.3390/jpm3040306
Mendeley helps you to discover research relevant for your work.